Patients with stage I–II diseases showed a trend to a longer survival time compared with those with stage III–IV diseases; however, there was no significant difference (P=0.08; Fig. 1B ).
← all excerpts
MicroRNAs associated with postoperative outcomes in patients with limited stage neuroendocrine carcinoma of the esophagus.
1
—
—